HANİFİ YILDIZ, SELAMİ EKİN, Ahmet ARISOY, HÜSEYİN AKDENİZ, SELVİ AŞKER, AYSEL SÜNNETÇİOĞLU, HÜLYA GÜNBATAR, Mehmet Hakan BİLGİN, MESUT ÖZGÖKÇE, MAHFUZ TURAN, Hasan Ali GÜMRÜKÇÜOĞLU, Nureddin YÜZKAT

Mortality and severity related factors during the admission: H1N1 pneumonia

In our country, fatal cases of H1N1 pneumonia were detected between 2015-2016 years. Our aim is to analyze the mortality and severity related factors, during admission of these patients. By conducting a retrospective analysis, 17 cases, confirmed to have H1N1 pneumonia, included in the study. Findings were compared in terms of ARDS and mortality. ICU and hospital mortality rates were 50% and 30%. The mean age of patients was 50 years. Serum LDH, CK, CK-MB, CRP AST, ALT levels, and the neutrophil-to-lymphocyte ratio (NLR) were found to be increased. In terms of coinfections, there wasn't a significant difference between died and survived patients. The mortality rate was 50% in patients with ARDS. There was no relationship between hospital stay with mortality. The symptom of restlessness was related to mortality, and presence of ARDS (P

PDF

___

The ANZIC Influenza Investigators: Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009; 2009: 1925- 1934.

Fujikura Y, Kawano S, Kouzaki Y, et al. Mortality and severity evaluation by routine pneumonia prediction models among Japanese patients with 2009 pandemic influenza A (H1N1) pneumonia. Respiratory investigation 2014; 52: 280-287.

Pereira JM, Moreno RP, Matos R, et al. ESICM H1N1 Registry Steering Committee; ESICM H1N1 Registry Contributors. Severity assessment tools in ICU patients with 2009 influenza A (H1N1) pneumonia. Clinical microbiology and infection 2012; 18: 1040-1048.

Torres SF, Iolster T, Schnitzler EJ, et al. High mortality in patients with influenza A pH1N1 2009 admitted to a pediatric intensive care unit: a predictive model of mortality. Pediatr Crit Care Med 2012; 13: 78-83.

Lockman JL, Fischer WA, Perl TM, Valsamakis A, Nichols DG. The critically ill child with novel H1N1 influenza A: a case series. Pediatric Critical Care Medicine 2010; 11: 173-178.

Indavarapu A, Akinapelli A. Neutrophils to lymphocyte ratio as a screening tool for swine influenza. Indian J Med Res 2011; 134: 389-391.

Deng LH, Zeng YL, Feng P, et al. Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China. Journal of Zhejiang University-Science B 2012; 13: 49-55.

Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes 2017; 10: 12.

Ishizuka M, Shimizu T, Kubota K. Neutrophil-tolymphocyte ratio has a close association with gangrenous appendicitis in patients undergoing appendectomy. Int Surg 2012; 97:299-304.

Perez-Padilla R, De la Rosa-Zamboni D, Ponce de Leon S, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361: 680-689.

Khan MY, Iqbal Z, Khan J, Amin M. ClinicoRadiological Profile, Polymerase Chain Reaction (PCR)-Positivity and Outcome-Analysis in Hospitalized Suspected H1N1 Pneumonia; Efficiency Assessment of health care delivery system. A Pilot Study. Pakistan Journal of Chest Medicine 2017; 22: 92-101.

Sohn CH, Ryoo SM, Yoon JY, et al. Comparison of clinical features and outcomes of hospitalized adult patients with novel influenza A (H1N1) pneumonia and other pneumonia. Acad Emerg Med 2013; 20: 46-53.

Örn Örnek T, Falçın FD, Ekin S, Yalçın Ş, Yemişen M. Pneumonia in patients with novel influenza A (H1N1) virus in Southeastern Turkey Wiener klinische Wochenschrift 2011; 123: 1613- 7671.

Çiftçi E, Karbuz A, Kendirli T. Influenza and the use of oseltamivir in children. Turkish Archives of Pediatrics 2016; 51: 63-71.

Nakamura K, Shirakura M, Fujisaki S, et al. Characterization of influenza A(H1N1)pdm09 viruses isolated from Nepalese and Indian outbreak patients in early 2015. Influenza and Other Respiratory Viruses 2017; 11: 1750-2659.

Singh A, Khera K, Agarwal J, Awasthi S, Francis J, Thunga G. Fatal prognosis of h1n1 influenza in late trimester of pregnancy: descriptive analysis of four cases. International Journal of Pharmacy and Pharmaceutical Sciences 2016; 8: 399-401.

Chong JL, Sapari S, Kuan YC. A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G. Journal of Microbiology, Immunology and Infection 2011; 44: 319-322.

Balis A, Warnes CM, Wu K, et al. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus-United States. MMWR Morbidity and mortality weekly report 2009; 58: 826-829.

Lim WS, Van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-382.

Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical infectious diseases 2007; 44: 27-72.

Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA: the journal of the American Medical Association 2012; 307: 2526-2533.

World Health Organization Global Alert and Response (GAR). Clinical management of human infection with pandemic (H1N1); revised guidance. November 2009. http://www.who.int/csr/resources/publications/s wineflu/clinical_management/en. Accessed on April 11, 2011.

Leymarie O, Jouvion G, Hervé PL, et al. Kinetic Characterization of PB1-F2-Mediated Immunopathology during Highly Pathogenic Avian H5N1 Influenza Virus Infection. Chan MCW, ed. PLoS ONE 2013; 8: e57894.

Su YC.F, Bahl J, Joseph U, et al. Nature Communications. Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection 2015; 6: 7952.

Juno J, Fowke KR, Keynan Y. Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses. Clin Dev Immunol 2012; 2012: 1-9.

Travanty E, Zhou B, Zhang H, et al. Virol 2015; 89: 11935-11944.

Camp JV, Chu YK, Chung DH, et al. Phenotypic Differences in Virulence and Immune Response in Closely Related Clinical Isolates of Influenza A 2009 H1N1 Pandemic Viruses in Mice. Brown EG, ed. PLoS ONE. 2013; 8: e56602. doi:10.1371/journal.pone.0056602.

Muthuri SG, Venkatesan S, Myles PR, et al. Impact of neuraminidase inhibitors on influenza A (H1N1) pdm09‐related pneumonia: an individual participant data meta‐analysis. Influenza and other respiratory viruses 2016; 10: 192-204.

Sertogullarindan B, Ozbay B, Gunini H, et al. Clinical and prognostic features of patients with pandemic 2009 influenza A (H1N1) virus in the intensive care unit. African health sciences 2011; 11: 163-170.

Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010; 362: 1708-1719.